Search results
Results from the WOW.Com Content Network
Cases of mycoplasma pneumoniae—walking pneumonia—are rising, the CDC warns. ... 2024 at 8:56 AM. ... the proportion of people leaving emergency rooms with a diagnosis of walking pneumonia has ...
Seniors are generally at higher risk for complications and death from pneumonia due to weakened immune systems. However, risk factors vary from person to person. ... 2024 at 8:59 AM ...
It is the most common bacterial pneumonia found in adults, the most common type of community-acquired pneumonia, and one of the common types of pneumococcal infection. The estimated number of Americans with pneumococcal pneumonia is 900,000 annually, with almost 400,000 cases hospitalized and fatalities accounting for 5-7% of these cases. [2]
Roughly 1 million adults in the U.S. seek hospital care due to pneumonia and 50,000 people die from it each year. "Pneumonia can become dangerous if it goes unrecognized and untreated.
Around 10% to 30% of non-hospitalised people with COVID-19 go on to develop long COVID. For those that do need hospitalisation, the incidence of long-term effects is over 50%. [76] Long COVID is an often severe multisystem disease with a large set of symptoms. There are likely various, possibly coinciding, causes. [76]
In COVID-19, the arterial and general tissue oxygen levels can drop without any initial warning.The chest x-ray may show diffuse pneumonia.Cases of silent hypoxia with COVID-19 have been reported for patients who did not experience shortness of breath or coughing until their oxygen levels had depressed to such a degree that they were at risk of acute respiratory distress (ARDS) and organ failure.
From Feb. 25 to March 2, the percentage of tests that came back positive for RSV was 2.6%, the California Department of Public Health said. That’s down from 3.5% the week before.
Antiviral treatment may be necessary for infected patients that end up in the intensive care unit (ICU) due to acute respiratory infection. Intravenous immunoglobulin is an FDA approved HCoV-NL63 inhibitor that is also used to treat primary immune deficiency , RSV , and Kawasaki disease , although it is not approved for the treatment of HCoV-NL63.